Agenus (AGEN) Projected to Post Earnings on Tuesday

Agenus (NASDAQ:AGEN) is expected to be announcing its earnings results before the market opens on Tuesday, March 11th. Analysts expect the company to announce earnings of ($2.36) per share and revenue of $30.09 million for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

Agenus Stock Performance

Shares of AGEN opened at $2.35 on Friday. The stock has a 50-day simple moving average of $3.27 and a 200-day simple moving average of $3.91. The stock has a market capitalization of $55.13 million, a PE ratio of -0.21 and a beta of 1.23. Agenus has a 1 year low of $2.31 and a 1 year high of $19.69.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reiterated a “neutral” rating on shares of Agenus in a research note on Wednesday, January 22nd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $10.00.

Agenus Company Profile

Agenus Inc, a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies.